MedImmune: Innovation through Implementation
28 September 2015
This article is brought to you by:
In 2014, MedImmune challenged the norms of how an ELN should be implemented. Within an eight-month timeframe, deployment took place across three sites in their entirety, from early discovery to clinical manufacturing, and included all of R&D. This article highlights how the ELN project team effectively challenged the status quo of how an ELN is selected, deployed and implemented
